Article
Factors associated with emergence of pristinamycin-resistant Staphylococcus aureus in a dermatology department: a case-control study.
The British journal of dermatology - 1 Aug 2010
Verneuil L, Marchand C, Vidal J S, Ze Bekolo R, Daurel C, Lebouvier G, Leroy D, Leclercq R
Abstract excerpt
BACKGROUND: Pristinamycin is used for the treatment of Staphylococcus aureus skin infection. Staphylococcus aureus pristinamycin resistance is usually low. The frequency of pristinamycin-resistant S. aureus (PRSA) increased in the Caen University Hospital dermatology department from 1% in 1998 to >11% in 1999-2002. OBJECTIVES: This study aimed to identify the factors associated with PRSA acquisition. METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
